Centre of Advanced Macromolecular Design (CAMD), The University of New South Wales, Sydney NSW 2052, Australia.
Biomacromolecules. 2011 May 9;12(5):1738-51. doi: 10.1021/bm200135e. Epub 2011 Apr 25.
Statistical and block copolymers based on poly(2-hydroxyethyl methacrylate) (PHEMA) and poly[oligo(ethylene glycol) methylether methacrylate] (POEGMEMA) were modified with 4-pentenoic anhydride or 4-oxo-4-(prop-2-ynyloxy)butanoic anhydride to generate polymers with pendant vinyl or acetylene, respectively. Subsequent thiol-ene or thiol-yne reaction with thioglycolic acid or 2-mercaptosuccinic acid leads to polymers with carboxylate functionalities, which were conjugated with cisplatin (cis-diamminedichloroplatinum(II) (CDDP)) to generate a drug carrier for Pt-drugs. Only the polymers modified with 2-mercaptosuccinic acid resulted in the formation of soluble well-defined polymers with gel formation being prevented. Due to the hydrophobicity of the drug, the block copolymers took on amphiphilic character leading to micelle formation. The micelles were in addition crosslinked to further stabilize their structure. Pt-containing statistical copolymer, micelles, and crosslinked micelles were then tested regarding their cellular uptake by the A549 lung cancer cell line to show a superior uptake of crosslinked micelles. However, due to the better Pt release of the statistical copolymer, the highest cytotoxicity was observed with this type of polymer architecture.
基于聚(2-羟乙基甲基丙烯酸酯)(PHEMA)和聚[聚(乙二醇)甲基醚甲基丙烯酸酯](POEGMEMA)的统计和嵌段共聚物分别用 4-戊烯酸酐或 4-氧代-4-(丙-2-炔氧基)丁二酸酐进行改性,分别生成带有侧乙烯基或乙炔基的聚合物。随后与巯基乙酸或 2-巯基琥珀酸进行硫醇-烯或硫醇-炔反应,生成带有羧酸盐官能团的聚合物,将其与顺铂(顺式-二氨二氯合铂(II)(CDDP))缀合,生成用于 Pt 药物的药物载体。只有用 2-巯基琥珀酸改性的聚合物才能形成可溶性的、明确的聚合物,从而防止凝胶形成。由于药物的疏水性,嵌段共聚物具有两亲性,导致胶束形成。此外,胶束还进行交联以进一步稳定其结构。然后对含有 Pt 的统计共聚物、胶束和交联胶束进行细胞摄取测试,以显示交联胶束具有更好的摄取效果。然而,由于统计共聚物具有更好的 Pt 释放,因此这种聚合物结构表现出最高的细胞毒性。